20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Deep-pocketed investors have adopted a bearish approach towards Humana (NYSE:HUM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HUM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 20 extraordinary options activities for Humana. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 20% leaning bullish and 50% bearish. Among these notable options, 9 are puts, totaling $861,597, and 11 are calls, amounting to $633,287.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $295.0 to $500.0 for Humana over the last 3 months.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of Humana stands at 505.4, with a total volume reaching 3,238.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Humana, situated within the strike price corridor from $295.0 to $500.0, throughout the last 30 days.
Humana Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUM | PUT | SWEEP | BEARISH | 01/17/25 | $100.4 | $93.5 | $96.6 | $400.00 | $241.5K | 695 | 25 |
| HUM | PUT | TRADE | BEARISH | 01/16/26 | $97.8 | $92.7 | $97.2 | $400.00 | $194.4K | 2.8K | 0 |
| HUM | CALL | SWEEP | BULLISH | 01/16/26 | $5.4 | $4.7 | $5.3 | $500.00 | $82.1K | 599 | 719 |
| HUM | PUT | SWEEP | NEUTRAL | 01/17/25 | $78.6 | $76.2 | $77.12 | $380.00 | $77.2K | 285 | 32 |
| HUM | PUT | SWEEP | NEUTRAL | 01/17/25 | $78.6 | $76.2 | $77.27 | $380.00 | $77.2K | 285 | 52 |
About Humana
Humana is one of the largest private health insurers in the US with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Having examined the options trading patterns of Humana, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Current Position of Humana
- With a trading volume of 748,991, the price of HUM is down by -0.77%, reaching $303.54.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 93 days from now.
Professional Analyst Ratings for Humana
In the last month, 5 experts released ratings on this stock with an average target price of $357.6.
- An analyst from Barclays persists with their Equal-Weight rating on Humana, maintaining a target price of $310.
- An analyst from Cantor Fitzgerald downgraded its action to Neutral with a price target of $391.
- An analyst from Goldman Sachs has decided to maintain their Buy rating on Humana, which currently sits at a price target of $385.
- An analyst from B of A Securities downgraded its action to Neutral with a price target of $342.
- An analyst from Cantor Fitzgerald has decided to maintain their Neutral rating on Humana, which currently sits at a price target of $360.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Humana options trades with real-time alerts from Benzinga Pro.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!